Virus and immune drug combo shows promise against stubborn breast cancer
NCT ID NCT03802604
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 35 times
Summary
This study tested a combination of two drugs—talimogene laherparepvec (T-VEC), a virus that attacks cancer cells, and atezolizumab, an immunotherapy—in 28 women with early-stage breast cancer that still had tumor left after standard chemotherapy. The goal was to see if this combo could shrink or eliminate the remaining cancer before surgery. The trial was early-stage and exploratory, so results are preliminary and not yet a proven treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centro Integral Oncológico Clara Campal
Madrid, Madrid, 28050, Spain
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
-
Hospital Clínico universitario de Valencia
Valencia, Valencia, 46010, Spain
-
Hospital Universitari Vall d'Hebrón
Barcelona, Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.